Prognostic Values of Systemic Inflammatory Immunological Markers in Glioblastoma: A Systematic Review and Meta-Analysis

Background. Neutrophils are an important part of the tumor microenvironment, which stimulates inflammatory processes through phagocytosis, degranulation, release of small DNA fragments (cell-free DNA), and presentation of antigens. Since neutrophils accumulate in peripheral blood in patients with ad...

Full description

Bibliographic Details
Main Authors: Pawel Jarmuzek, Klaudia Kozlowska, Piotr Defort, Marcin Kot, Agnieszka Zembron-Lacny
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/15/13/3339
_version_ 1797591995872444416
author Pawel Jarmuzek
Klaudia Kozlowska
Piotr Defort
Marcin Kot
Agnieszka Zembron-Lacny
author_facet Pawel Jarmuzek
Klaudia Kozlowska
Piotr Defort
Marcin Kot
Agnieszka Zembron-Lacny
author_sort Pawel Jarmuzek
collection DOAJ
description Background. Neutrophils are an important part of the tumor microenvironment, which stimulates inflammatory processes through phagocytosis, degranulation, release of small DNA fragments (cell-free DNA), and presentation of antigens. Since neutrophils accumulate in peripheral blood in patients with advanced-stage cancer, a high neutrophil-to-lymphocyte ratio can be a biomarker of a poor prognosis in patients with glioblastoma. The present study aimed to explore the prognostic value of the preoperative levels of neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune inflammation index (SII), systemic inflammation response index (SIRI), and cell-free DNA (cfDNA) to better predict prognostic implications in the survival rate of glioblastoma patients. Methods. The meta-analysis was carried out according to the recommendations and standards established by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses. Databases of PubMed, EBSCO, and Medline were systematically searched to select all the relevant studies published up to December 2022. Results. Poorer prognoses were recorded in patients with a high NLR or PLR when compared with the patients with a low NLR or PLR (HR 1.51, 95% CI 1.24–1.83, <i>p</i> < 0.0001 and HR 1.34, 95% CI 1.10–1.63, <i>p</i> < 0.01, respectively). Similarly, a worse prognosis was reported for patients with a higher cfDNA (HR 2.35, 95% CI 1.27–4.36, <i>p</i> < 0.01). The SII and SIRI values were not related to glioblastoma survival (<i>p</i> = 0.0533 and <i>p</i> = 0.482, respectively). Conclusions. Thus, NLR, PLR, and cfDNA, unlike SII and SIRI, appeared to be useful and convenient peripheral inflammatory markers to assess the prognosis in glioblastoma.
first_indexed 2024-03-11T01:46:31Z
format Article
id doaj.art-d3bbf7198c5648a49538d0700959fb74
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-11T01:46:31Z
publishDate 2023-06-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-d3bbf7198c5648a49538d0700959fb742023-11-18T16:15:34ZengMDPI AGCancers2072-66942023-06-011513333910.3390/cancers15133339Prognostic Values of Systemic Inflammatory Immunological Markers in Glioblastoma: A Systematic Review and Meta-AnalysisPawel Jarmuzek0Klaudia Kozlowska1Piotr Defort2Marcin Kot3Agnieszka Zembron-Lacny4Department of Nervous System Diseases, Collegium Medicum University of Zielona Gora, Neurosurgery Center University Hospital in Zielona Gora, 65-417 Zielona Gora, PolandDepartment of Biomedical Engineering, Faculty of Fundamental Problems of Technology, Wroclaw University of Science and Technology, 50-370 Wroclaw, PolandDepartment of Nervous System Diseases, Collegium Medicum University of Zielona Gora, Neurosurgery Center University Hospital in Zielona Gora, 65-417 Zielona Gora, PolandDepartment of Nervous System Diseases, Collegium Medicum University of Zielona Gora, Neurosurgery Center University Hospital in Zielona Gora, 65-417 Zielona Gora, PolandDepartment of Applied and Clinical Physiology, Collegium Medicum University of Zielona Gora, 65-417 Zielona Gora, PolandBackground. Neutrophils are an important part of the tumor microenvironment, which stimulates inflammatory processes through phagocytosis, degranulation, release of small DNA fragments (cell-free DNA), and presentation of antigens. Since neutrophils accumulate in peripheral blood in patients with advanced-stage cancer, a high neutrophil-to-lymphocyte ratio can be a biomarker of a poor prognosis in patients with glioblastoma. The present study aimed to explore the prognostic value of the preoperative levels of neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune inflammation index (SII), systemic inflammation response index (SIRI), and cell-free DNA (cfDNA) to better predict prognostic implications in the survival rate of glioblastoma patients. Methods. The meta-analysis was carried out according to the recommendations and standards established by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses. Databases of PubMed, EBSCO, and Medline were systematically searched to select all the relevant studies published up to December 2022. Results. Poorer prognoses were recorded in patients with a high NLR or PLR when compared with the patients with a low NLR or PLR (HR 1.51, 95% CI 1.24–1.83, <i>p</i> < 0.0001 and HR 1.34, 95% CI 1.10–1.63, <i>p</i> < 0.01, respectively). Similarly, a worse prognosis was reported for patients with a higher cfDNA (HR 2.35, 95% CI 1.27–4.36, <i>p</i> < 0.01). The SII and SIRI values were not related to glioblastoma survival (<i>p</i> = 0.0533 and <i>p</i> = 0.482, respectively). Conclusions. Thus, NLR, PLR, and cfDNA, unlike SII and SIRI, appeared to be useful and convenient peripheral inflammatory markers to assess the prognosis in glioblastoma.https://www.mdpi.com/2072-6694/15/13/3339brain tumorcell-free DNAinflammationneutrophilsplateletsprognosticators
spellingShingle Pawel Jarmuzek
Klaudia Kozlowska
Piotr Defort
Marcin Kot
Agnieszka Zembron-Lacny
Prognostic Values of Systemic Inflammatory Immunological Markers in Glioblastoma: A Systematic Review and Meta-Analysis
Cancers
brain tumor
cell-free DNA
inflammation
neutrophils
platelets
prognosticators
title Prognostic Values of Systemic Inflammatory Immunological Markers in Glioblastoma: A Systematic Review and Meta-Analysis
title_full Prognostic Values of Systemic Inflammatory Immunological Markers in Glioblastoma: A Systematic Review and Meta-Analysis
title_fullStr Prognostic Values of Systemic Inflammatory Immunological Markers in Glioblastoma: A Systematic Review and Meta-Analysis
title_full_unstemmed Prognostic Values of Systemic Inflammatory Immunological Markers in Glioblastoma: A Systematic Review and Meta-Analysis
title_short Prognostic Values of Systemic Inflammatory Immunological Markers in Glioblastoma: A Systematic Review and Meta-Analysis
title_sort prognostic values of systemic inflammatory immunological markers in glioblastoma a systematic review and meta analysis
topic brain tumor
cell-free DNA
inflammation
neutrophils
platelets
prognosticators
url https://www.mdpi.com/2072-6694/15/13/3339
work_keys_str_mv AT paweljarmuzek prognosticvaluesofsystemicinflammatoryimmunologicalmarkersinglioblastomaasystematicreviewandmetaanalysis
AT klaudiakozlowska prognosticvaluesofsystemicinflammatoryimmunologicalmarkersinglioblastomaasystematicreviewandmetaanalysis
AT piotrdefort prognosticvaluesofsystemicinflammatoryimmunologicalmarkersinglioblastomaasystematicreviewandmetaanalysis
AT marcinkot prognosticvaluesofsystemicinflammatoryimmunologicalmarkersinglioblastomaasystematicreviewandmetaanalysis
AT agnieszkazembronlacny prognosticvaluesofsystemicinflammatoryimmunologicalmarkersinglioblastomaasystematicreviewandmetaanalysis